|
Dear Edson Neto, |
Based on the papers you've read, we think you might be interested in this recently published article from Academia Oncology: The importance of ever-evolving phase 1 trials in oncology
|
|
|
Andreas Domen, Pieterjan Vanclooster, Laure-Anne Teuwen, Bernd Dekeyser, Timon Vandamme, Hans Prenen
|
|
|
|---|
|
|---|
|
| Phase 1 clinical trials are a critical step in oncology drug development. Historically, these first-in-human trials focused on dose–toxicity profiling in heterogeneous populations. With the emergence of novel anticancer therapies, trial design has shifted toward model-based and adaptive dose-escalation designs,... Read more |
|
|
|---|
|
|
Academia Oncology is an innovative open access journal publishing original research and review articles covering all areas of oncology. The editors welcome interdisciplinary submissions from the cutting edge of oncology research, in particular, those that drive connectivity between disciplines. |
|
|
|---|
|
|
|
|
Read later